Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2025)

Historic Inventory for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $5.7 million.

  • Tonix Pharmaceuticals Holding's Inventory fell 2776.45% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 2776.45%. This contributed to the annual value of $8.4 million for FY2024, which is 3835.33% down from last year.
  • Tonix Pharmaceuticals Holding's Inventory amounted to $5.7 million in Q3 2025, which was down 2776.45% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Inventory registered a high of $13.7 million during Q2 2023, and its lowest value of $5.7 million during Q3 2025.
  • Moreover, its 3-year median value for Inventory was $8.9 million (2024), whereas its average is $9.9 million.
  • Its Inventory has fluctuated over the past 5 years, first tumbled by 4053.83% in 2024, then plummeted by 2776.45% in 2025.
  • Tonix Pharmaceuticals Holding's Inventory (Quarter) stood at $13.6 million in 2023, then crashed by 38.35% to $8.4 million in 2024, then tumbled by 31.86% to $5.7 million in 2025.
  • Its last three reported values are $5.7 million in Q3 2025, $6.0 million for Q2 2025, and $8.1 million during Q1 2025.